卵巢癌筛查:影像学挑战与改进机遇
英国卵巢癌筛查协作试验(UKCTOCS)报告,采用年度序贯多模式策略(追踪CA125,升高时行超声)筛查可降低卵巢癌患者平均总死亡率。但CA125升高而超声正常导致手术延迟的病例多有记录,假阴性可能与输卵管伞端上皮起源肿瘤难以成像及部分转移瘤在超声可检出前已转移有关。未来应聚焦侵袭性早期肿瘤特异性特征、提高影像灵敏度以检出输卵管病变,并探索三阶段多模式筛查策略。
要点
- UKCTOCS报告年度序贯多模式筛查(CA125升高后超声)可降低卵巢癌患者平均总死亡率。
- CA125升高而超声正常导致手术延迟的假阴性病例多有记录,输卵管伞端病变难以成像。
- 未来应提高影像灵敏度以检出输卵管病变,并探索三阶段多模式筛查策略。
核心结论
- UKCTOCS报告年度序贯多模式筛查可降低卵巢癌患者平均总死亡率,但CA125升高而超声正常导致手术延迟的假阴性病例多有记录。
- 未来改进筛查应聚焦侵袭性早期肿瘤特异性特征及提高影像灵敏度以检出输卵管病变,三阶段多模式筛查策略可能有助于检出超声漏诊的早期病例。
研究设计与样本
- 本文为综述,围绕UKCTOCS报告的年度序贯多模式筛查策略(追踪CA125,升高时行超声)及影像学挑战进行讨论。
主要发现
- UKCTOCS报告,采用年度序贯多模式策略追踪CA125(升高时行超声)筛查的卵巢癌患者平均总死亡率降低。
- 多例CA125升高但超声筛查正常,导致手术干预延迟。
- 许多侵袭性卵巢癌被认为起源于输卵管伞端上皮细胞,该部位不易成像。
- 仅一部分转移瘤在转移前可能达到超声可检出大小,年度超声筛查可能漏检很大一部分早期卵巢癌。
临床怎么用
- 作者认为,未来改进筛查应聚焦识别侵袭性早期肿瘤的特异性特征,并提高影像灵敏度以检出输卵管病变。
- 作者认为,实施三阶段多模式筛查策略(一线血液检测阳性而二线超声阴性时采用第三种模态)可能有助于检出超声漏诊的早期病例。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) recently reported a reduction in the average overall mortality among ovarian cancer patients screened with an annual sequential, multimodal strategy that tracked biomarker CA125 over time, where increasing serum CA125 levels prompted ultrasound. However, multiple cases were documented wherein serum CA125 levels were rising, but ultrasound screens were normal, thus delaying surgical intervention. A significant factor which could contribute to false negatives is that many aggressive ovarian cancers are believed to arise from epithelial cells on the fimbriae of the fallopian tubes, which are not readily imaged. Moreover, because only a fraction of metastatic tumors may reach a sonographically-detectable size before they metastasize, annual screening with ultrasound may fail to detect a large fraction of early-stage ovarian cancers. The ability to detect ovarian carcinomas before they metastasize is critical and future efforts towards improving screening should focus on identifying unique features specific to aggressive, early-stage tumors, as well as improving imaging sensitivity to allow for detection of tubal lesions. Implementation of a three-stage multimodal screening strategy in which a third modality is employed in cases where the first-line blood-based assay is positive and the second-line ultrasound exam is negative may also prove fruitful in detecting early-stage cases missed by ultrasound.
引用
- Mathieu KB, Bedi DG, Thrower SL, et al. Screening for ovarian cancer: imaging challenges and opportunities for improvement. Ultrasound Obstet Gynecol. 2018. PMID: 28639753. doi:10.1002/uog.17557
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。